论文部分内容阅读
目的:分析探究珂立苏配合气管插管治疗早产新生儿呼吸窘迫的临床效果。方法:2013年5月至2015年5月期间,我院接收早产新生儿呼吸窘迫患者共计89例,按照住院时间顺序依次编号,前44例患者接受无珂立苏常规治疗,为对照组,另45例患者接受珂立苏配合气管插管治疗,比较两个组别患者术后的呼吸情况。结果:两组患者经过系统治疗后,临床症状基本得到改善,试验组患者SpO2指标为92%-93%,自主呼吸改善情况的成功率为86.36%,对照组的SpO2指标为70.45%,自主呼吸改善情况成功率为28.89%,组间试验组改善情况明显优于对照组,上述差异显著,具有统计学意义(P<0.05)。结论:对于早产新生儿呼吸窘迫应用珂立苏配合气管插管的临床效果更佳,有较高的呼吸改善成功率,临床效果更佳。
Objective: To analyze the clinical effect of Ke Li Su with tracheal intubation in the treatment of respiratory distress in premature neonates. Methods: From May 2013 to May 2015, a total of 89 patients with respiratory distress were recruited in our hospital from January 2013 to May 2015. The patients were sequentially numbered according to the length of hospital stay. The first 44 patients received routine treatment of Rhizoma Acori, and were the control group. Forty-five patients were treated with Coriolis in combination with endotracheal intubation, and the respiration of the two groups was compared. Results: After treatment, the clinical symptoms were basically improved in both groups. The SpO2 index was 92% -93% in the test group, the improvement rate of spontaneous breathing was 86.36%, the control group’s SpO2 index was 70.45% The success rate of improvement was 28.89%. The improvement of the experimental group was obviously better than that of the control group. The difference was significant and statistically significant (P <0.05). Conclusion: The clinical effect of applying Ke Li Su with tracheal intubation for respiratory distress in premature neonates is better, and the success rate of breathing improvement is better, and the clinical effect is better.